MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Migard 2.5mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Stability Notes

No special precautions for storage.

Provenance

Compatibility information derived from Zavesca 100mg capsules (Janssen-Cilag Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatibility information derived from Zavesca 100mg capsules (Janssen-Cilag Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatibility information derived from Zavesca 100mg capsules (Janssen-Cilag Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatibility information derived from Zavesca 100mg capsules (Janssen-Cilag Ltd).

Stability Notes

No special storage requirements.

Provenance

This compatibility recommendation is derived from Imigran Radis 50mg tablets (GlaxoSmithKline UK Ltd), Imigran 50mg tablets (GlaxoSmithKline UK Ltd) and generic sumatriptan 50mg tablets.

Stability Notes

No special storage requirements.

Provenance

This compatibility recommendation is derived from Imigran Radis 50mg tablets (GlaxoSmithKline UK Ltd), Imigran 50mg tablets (GlaxoSmithKline UK Ltd) and generic sumatriptan 50mg tablets.

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.